PubRank

Alan R Schned

Author PubWeight™ 38.56‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Implications of LINE1 methylation for bladder cancer risk in women. Clin Cancer Res 2010 2.10
2 Concordance of multiple analytical approaches demonstrates a complex relationship between DNA repair gene SNPs, smoking and bladder cancer susceptibility. Carcinogenesis 2005 2.08
3 Clinical and immunologic effects of intranodal autologous tumor lysate-dendritic cell vaccine with Aldesleukin (Interleukin 2) and IFN-{alpha}2a therapy in metastatic renal cell carcinoma patients. Clin Cancer Res 2009 1.94
4 Ureteroscopic biopsy of upper tract urothelial carcinoma using a novel ureteroscopic biopsy forceps. Can J Urol 2012 1.46
5 Bladder cancer SNP panel predicts susceptibility and survival. Hum Genet 2009 1.43
6 Epigenetic inactivation of SFRP genes and TP53 alteration act jointly as markers of invasive bladder cancer. Cancer Res 2005 1.40
7 Promoter hypermethylation is associated with current smoking, age, gender and survival in bladder cancer. Carcinogenesis 2007 1.40
8 Electrical impedance spectroscopy of the human prostate. IEEE Trans Biomed Eng 2007 1.39
9 Microsatellite instability at tetranucleotide repeats in skin and bladder cancer. Oncogene 2002 1.33
10 Identification of methylated genes associated with aggressive bladder cancer. PLoS One 2010 1.27
11 The diaphragms of fenestrated endothelia: gatekeepers of vascular permeability and blood composition. Dev Cell 2012 1.13
12 Pseudolipomatosis in hysteroscopically resected tissues from the gynecologic tract: pathologic description and frequency. Am J Surg Pathol 2009 1.07
13 Occupation and bladder cancer risk in a population-based case-control study in New Hampshire. Cancer Causes Control 2004 1.06
14 Recurrent perivascular epithelioid cell tumor of the uterus (PEComa): an immunohistochemical study and review of the literature. Gynecol Oncol 2003 0.97
15 Correlation of LINE-1 methylation levels in patient-matched buffy coat, serum, buccal cell, and bladder tumor tissue DNA samples. Cancer Epidemiol Biomarkers Prev 2012 0.94
16 Developing a rational tumor vaccine therapy for renal cell carcinoma: immune yin and yang. Clin Cancer Res 2007 0.93
17 Bladder cancer risk and personal hair dye use. Int J Cancer 2004 0.92
18 EGFR pathway polymorphisms and bladder cancer susceptibility and prognosis. Carcinogenesis 2009 0.92
19 Distinct mechanisms of action of anti-CD154 in early versus late treatment of murine lupus nephritis. Arthritis Rheum 2003 0.90
20 Association of secondhand smoke exposures with DNA methylation in bladder carcinomas. Cancer Causes Control 2011 0.90
21 Body mass and smoking are modifiable risk factors for recurrent bladder cancer. Cancer 2013 0.90
22 Scrotal lymphangioma: an uncommon cause for a scrotal mass. J Ultrasound Med 2002 0.90
23 Genetic variant as a selection marker for anti-prostate stem cell antigen immunotherapy of bladder cancer. J Natl Cancer Inst 2012 0.88
24 HSD3B and gene-gene interactions in a pathway-based analysis of genetic susceptibility to bladder cancer. PLoS One 2012 0.88
25 DNA repair genotype interacts with arsenic exposure to increase bladder cancer risk. Toxicol Lett 2009 0.86
26 Impaired cytolytic activity in peripheral blood T cells from renal cell carcinoma patients. Clin Immunol 2005 0.84
27 Priapism in a 15-year-old boy with congenital dyserythropoietic anemia type II (hereditary erythroblastic multinuclearity with positive acidified serum lysis test). J Urol 2002 0.84
28 Tumor-related immunity in prostate cancer patients treated with human recombinant granulocyte monocyte-colony stimulating factor (GM-CSF). Prostate 2006 0.83
29 Passive bioelectrical properties for assessing high- and low-grade prostate adenocarcinoma. Prostate 2011 0.83
30 Arsenic exposure predicts bladder cancer survival in a US population. World J Urol 2009 0.83
31 Cell-cycle control in urothelial carcinoma: large-scale tissue array analysis of tumor tissue from Maine and Vermont. Cancer Epidemiol Biomarkers Prev 2012 0.82
32 Intake of α-linolenic acid and other fatty acids in relation to the risk of bladder cancer: results from the New Hampshire case-control study. Br J Nutr 2011 0.81
33 Genetic polymorphisms modify bladder cancer recurrence and survival in a USA population-based prognostic study. BJU Int 2014 0.80
34 Intraperitoneal India ink deposits appearing as endometriosis in a patient with chronic pelvic pain. Obstet Gynecol 2008 0.80
35 Immunological effects of granulocyte-macrophage colony-stimulating factor and autologous tumor vaccine in patients with renal cell carcinoma. J Urol 2004 0.76
36 Prostate Cancer Detection Using Composite Impedance Metric. IEEE Trans Med Imaging 2016 0.75
37 Ovarian strumal carcinoid producing peptide YY associated with severe constipation: a case report and review of the literature. Int J Gynecol Pathol 2015 0.75
38 Real-time polymerase chain reaction and laser capture microdissection for the diagnosis of BK virus infection in renal allografts. Am J Clin Pathol 2005 0.75
39 Best cases from the AFIP: testicular seminoma with lymph node metastases. Radiographics 2009 0.75
40 Gliomatosis peritonei and teratomatous implant with carcinomatous transformation presenting 54 years following oophorectomy for dermoid cyst. Gynecol Oncol 2004 0.75
41 Comparative study of separation between ex-vivo prostatic malignant and benign tissue using electrical impedance spectroscopy and electrical impedance tomography. Physiol Meas 2017 0.75
42 Polyomavirus infection of the urinary tract presenting as hemorrhagic cystitis in an immunocompetent five-year-old boy. Diagn Cytopathol 2008 0.75
43 Stromal lipofuscinosis of the seminal vesicle. Pathology 2010 0.75